Evicenter
MarkdownMedical informationP&T meetings
Onvuzosiran (ADX-324)

Prophylaxis of hereditary angioedema attacks

Launch
Not announced
Last updated
119 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care

Progestins

1 evidence topic · 1 source

Progestin prophylaxis: variant-specific observational evidence
FeatureGuideline description
Subtype with reported responses“HAE-FXII”
Reported response“Favourable responses”
Evidence for other variants“limited evidence for other HAE-nC1INH variants.”